A Case of Coumarin Embryopathy After in Utero Exposure to Acenocoumarol

Ankur Singh1, Astha Panghal1, Rajniti Prasad1, Om Prakash Mishra1
1Genetic Clinic, Department of Paediatrics, Institute Of Medical Sciences, Banaras Hindu University, Varanasi, India

Tóm tắt

Coumarins (warfarin, acenocoumarol, phenprocuomon) are well known agents that are prescribed for prevention of thromboembolic episodes in pregnant women who are on mechanical heart valves prosthesis. It acts as double edge sword as fetus is unnecessarily exposed to teratogenic effect of drug. Warfarin is well studied drug in terms of its tetratogenic dose, period of exposure, fetopathic effects. Acenocoumarol is well known teratogen but its effect and lethal dose on fetus is less reported. We report a neonate who was exposed to acenocoumarol throughout intra uterine life. Neonate showed all features of coumarin embryopathy (flat facial profile, depressed nasal bridge, short columella, skeletal stippling, short distal phalanges in hand) and cephalhaematoma in addition. We also summarised the clinical findings of all the cases reported so far of acenocoumarol embryopathy. Acenocoumarol has same teratogenic potential as of warfarin. Doses causing embryopathy remained unexplored field. Clinicians need to document properly so that scientific data can be generated as ethical issues arises in head to head trial of these drugs.

Từ khóa


Tài liệu tham khảo

Ban A. Long-term treatment with coumarin preparations in advanced age. Z Gesamte Inn Med. 1984;39:617–20.

Vigue B. Bench-to-bedside review: optimising emergency reversal of vitamin K antagonists in severe hemorrhage—from theory to practice. Crit Care. 2009;13:209.

Van Driel D, Wesseling J, Sauer PJ, et al. Teratogen update: fetal effects after in utero exposure to coumarins overview of cases, follow-up findings, and pathogenesis. Teratology. 2002;66:127–40.

McLintock C. Anticoagulant therapy in pregnant women with mechanical prosthetic heart valves: no easy option. Thromb Res. 2011;127:S56–60.

Panduranga P, El-Deeb M, Jha C. Mechanical prosthetic valves and pregnancy: a therapeutic dilemma of anticoagulation. Sultan Qaboos Univ Med J. 2014;14:e448–54.

Suri V, Keepanasseril A, Aggarwal N, et al. Mechanical valve prosthesis and anticoagulation regimens in pregnancy: a tertiary centre experience. Eur J Obstet Gynecol Reprod Biol. 2011;159:320–3.

Prieto AL, Weber JL, Tracy S, et al. Gas6, a ligand for the receptor protein-tyrosine kinase Tyro-3, is widely expressed in the central nervous system. Brain Res. 1999;816:646–61.

Hou JW. Fetal warfarin syndrome. Chang Gung Med J. 2004;27:691–5.

Becker MH, Genieser NB, Finegold M, et al. Chondrodysplasia Punctata. Is maternal warfarin therapy a factor? Am J Dis Child. 1975;129:356–9.

Howe AM, Webster WS. Vitamin K: its essential role in craniofacial development. A review of the literature regarding vitamin K and craniofacial development. Aust Dent J. 1994;39:88–92.

Vanlaeys R, Deroubaix P, Deroubaix G, et al. Les antivitamines K sont-elles te´ratoge`nes? Nouv Press Med. 1977;6:756.

Weenink GH, van Dijk-Wierda CA, Meyboom RH, et al. Teratogenic effect of coumarin derivatives. Ned Tijdschr Geneeskd. 1981;125:702–6.

Lapiedra OJ, Bernal JM, Ninot S, et al. Open heart surgery for thrombosis of a prosthetic mitral valve during pregnancy. Fetal hydrocephalus. J Cardiovasc Surg (Torino). 1986;27:217–20.

De Vries TW, Van der Veer E, Heymans HSA. Warfarin embryopathy: patient, possibility, pathogenesis and prognosis. Br J Obstet Gynaecol. 1993;100:869–71.

Van Driel D, Wesseling J, De Vries TW, et al. Coumarin embryopathy: follow-up of two cases. Eur J Pediatr. 2002;161:231–2.

Bony C, Zyka F, Tiran-Rajaofera I, et al. Warfarin fetopathy. Arch Pediatr. 2002;9:705–8.

Robinow M, Johnson GF. Dermatoglyphics in distal phalangeal hypoplasia. Am J Dis Child. 1972;124:860–3.

Hassouna A, Allam H. Limited dose warfarin throughout pregnancy in patients with mechanical heart valve prosthesis: a meta-analysis. Interact CardioVasc Thorac Surg. 2014;18:797–806.

Hall JG, Pauli RM, Wilson KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med. 1980;68:122–40.